Immunology
Human polymorphisms in GSDMD alter the inflammatory response

https://doi.org/10.1074/jbc.RA119.010604Get rights and content
Under a Creative Commons license
open access

Exomic studies have demonstrated that innate immune genes exhibit an even higher degree of variation than the majority of other gene families. However, the phenotypic implications of this genetic variation are not well understood, with effects ranging from hypomorphic to silent to hyperfunctioning. In this work, we study the functional consequences of this variation by investigating polymorphisms in gasdermin D, the key pyroptotic effector protein. We find that, although SNPs affecting potential posttranslational modifications did not affect gasdermin D function or pyroptosis, polymorphisms disrupting sites predicted to be structurally important dramatically alter gasdermin D function. The manner in which these polymorphisms alter function varies from conserving normal pyroptotic function to inhibiting caspase cleavage to disrupting oligomerization and pore formation. Further, downstream of inflammasome activation, polymorphisms that cause loss of gasdermin D function convert inflammatory pyroptotic cell death into immunologically silent apoptotic cell death. These findings suggest that human genetic variation can alter mechanisms of cell death in inflammation.

cell death
inflammasome
genetics
inflammation
genetic polymorphism
SNP

Cited by (0)

This work was supported by NIDDK, National Institutes of Health Grant P01DK091222 (to D. W. A.); NIGMS, National Institutes of Health Grant R01GM086550 (to D. W. A.); and National Institutes of Health Grants R21AR069908 and R01GM127609 (to T. S. X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

This article contains Fig. S1.

1

Supported by NIGMS, National Institutes of Health Grant T32 GM007250.